 Ocular Therapeutix, Inc. NASDAQ:OCUL Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Donald Notman - CFO Antony Mattessich - President, CEO Director Rabia Ozden - Chief Medical Officer Conference Call Participants Jonathan Wolleben - JMP Securities Stacy Ku - Cowen and Company Yi Chen - H.C. Wainwright Co. Joseph Catanzaro - Piper Sandler Co. Operator Good afternoon, ladies and gentlemen. 